Mdxhealth to Release First Quarter 2025 Financial Results on May 14
Rhea-AI Summary
MDxHealth, a precision diagnostics company listed on NASDAQ (MDXH), has scheduled the release of its first quarter 2025 financial results for May 14, 2025, after market close. The company will host a conference call and webcast at 4:30pm ET / 22:30 CET on the same day.
CEO Michael K. McGarrity and CFO Ron Kalfus will lead the presentation. Investors can join via multiple regional dial-in numbers:
- United States: 1-844-825-9789
- Belgium: 0800 38 961
- Netherlands: 0800 94 94 506
- United Kingdom: 0808 238 9064
Participants should access the webcast 15 minutes before the start time using Conference ID 10199102. A replay will be available on the company's website after the live call.
Positive
- None.
Negative
- None.
News Market Reaction – MDXH
On the day this news was published, MDXH gained 0.58%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET
IRVINE, California – April 30, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2025, after market close on Wednesday, May 14, 2025.
| Title: | Mdxhealth Presents First Quarter 2025 Financial Results and Corporate Update Conference Call and Webcast |
| Speakers: | Michael K. McGarrity, Chief Executive Officer Ron Kalfus, Chief Financial Officer |
| Date: | May 14, 2025 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064 |
| Conference ID: | 10199102 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1716341&tp_key=092e4b795e |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
| MDxHealth info@mdxhealth.com | |
| LifeSci Advisors (IR & PR) US: +1 949 271 9223 ir@mdxhealth.com |
FAQ
When will MDxHealth (MDXH) release Q1 2025 financial results?
How can investors join MDxHealth's Q1 2025 earnings call?
What is the conference ID for MDXH's Q1 2025 earnings call?
Will there be a replay available for MDxHealth's Q1 2025 earnings call?
What time does MDXH's Q1 2025 earnings call start in European time?
